Drug Type Small molecule drug |
Synonyms TR 14531 |
Target |
Action antagonists |
Mechanism α4β1 antagonists(Integrin alpha-4/beta-1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC34H34N2O7S |
InChIKeyYQQUBIXUFFJEJC-FGUUHEIUSA-N |
CAS Registry676124-97-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Phase 1 | United States | - |